Welcome to the media kit for Symbyax™, the first FDA-approved medication for bipolar depression. This online press kit is designed to bring you essential facts and background materials to help you tell the story about bipolar depression and Symbyax (olanzapine and fluoxetine HCl), approved for the treatment of depressive episodes associated with bipolar depression.
Downloadable Symbyax™ Images
- Symbyax™ Logo
- Symbyax™ Product Photos
Media Kit Materials
- Symbyax™ Approval Press Release (PDF) - 12/29/03
- Symbyax™ Fact Sheet (PDF)
- Bipolar Disorder Backgrounder (PDF)
- Bipolar Disorder Animation File (PDF)
Important Note: You must have Acrobat Reader version 4.0 or higher installed to view these files. If you have an earlier version installed, an update is available from the Adobe Acrobat Reader download site.
